PARACETAMOL MABO-FARMA 1 g TABLETS

2. What you need to know before taking Paracetamol MABO-FARMA

Do not take Paracetamol MABO-FARMA:

If you are allergic to paracetamol or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions:

Consult your doctor or pharmacist or nurse before starting to take Paracetamol.

• when used by patients on a sodium-free or low-sodium diet (see "Paracetamol MABO-FARMA contains sodium").

Paracetamol may cause severe skin reactions, such as acute generalized exanthematous pustulosis (AGEP), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN), which can be fatal. Patients should be informed about the symptoms of severe skin reactions and the use of the medicine should be discontinued at the first sign of skin rash or any other symptom of hypersensitivity.

The maximum recommended dose should not exceed 4 g.

Concomitant use of this medicine with other medicines containing paracetamol, such as flu and cold medicines, should be avoided, as high doses can cause liver damage. Do not use more than one medicine containing paracetamol without consulting your doctor.

If you suffer an overdose, seek medical attention immediately (see "If you take more Paracetamol MABO-FARMA than you should").

Administration of paracetamol doses higher than recommended implies a very serious risk of liver injury. Medicines containing paracetamol should not be taken for more than a few days or in high doses, unless your doctor indicates otherwise.

Prolonged use of pain relievers, or inadequate use of high doses, can cause headaches, which should not be treated with higher doses of the medicine.

During treatment with Paracetamol MABO-FARMA, inform your doctor immediately if: you have serious illnesses, such as severe kidney failure or sepsis (when bacteria and their toxins circulate in the blood, causing organ damage), or if you have malnutrition, chronic alcoholism, or if you are also taking flucloxacillin (an antibiotic). A serious disease called metabolic acidosis (an anomaly in the blood and fluids) has been reported in patients in these situations when paracetamol is used at regular doses for a prolonged period or when paracetamol is taken with flucloxacillin. The symptoms of metabolic acidosis may include: severe breathing difficulties with deep and rapid breathing, drowsiness, feeling unwell (nausea) and vomiting.

Interference with laboratory tests

If you are going to have any laboratory tests (including blood, urine, etc.), inform your doctor that you are taking this medicine, as it may alter the results.

Paracetamol may alter the values of analytical determinations of uric acid and glucose.

Children and Adolescents

This medicine is not recommended for children (see section 3). This medicine is indicated only for adults and adolescents over 15 years old and weighing more than 55 kg.

In children under 15 years old or weighing less than 55 kg, consult your doctor or pharmacist, as other presentations may be available with doses suitable for these patients.

Other Medicines and Paracetamol

Inform your doctor or pharmacist if you are using or have recently used or may need to use other medicines.

In particular, if you are using any of the following medicines, it may be necessary to modify the dose of some of them or interrupt treatment:

Medicines to treat seizures (antiepileptics such as carbamazepine, phenytoin, phenobarbital, primidone, lamotrigine): the combination of paracetamol and antiepileptic medicines may cause or worsen liver damage.

Lamotrigine: The effect of lamotrigine may decrease.

Medicines to treat high blood pressure and heart rhythm disorders (arrhythmias) (propranolol): the combination of paracetamol and propranolol may increase the action and/or toxicity.

Medicines to treat gout: Probenecid causes a reduction of almost 2 times in the excretion of paracetamol. The dose of paracetamol should be considered for reduction when concomitant treatment with probenecid is administered.

Medicines to treat tuberculosis (rifampicin, isoniazid): the combination of paracetamol and rifampicin or isoniazid may cause or worsen liver damage.

Salicylamide, a medicine to treat fever and pain, may prolong the elimination half-life (t1/2) of paracetamol.

Medicines to reduce cholesterol levels in the blood: colestyramine reduces the absorption of paracetamol. To avoid this, paracetamol should be administered one hour before or 4 hours after the resin.

Medicines to prevent nausea and vomiting (metoclopramide and domperidone): the simultaneous ingestion of medicines that cause gastric emptying acceleration, e.g., metoclopramide and domperidone, increases the absorption and anticipates the onset of the action of paracetamol. However, it is not necessary to avoid concomitant use.

Medicines to prevent blood clots (oral anticoagulants such as acenocoumarol, warfarin): paracetamol may increase the effects of oral anticoagulants. Prolonged use of this medicine in patients treated with oral anticoagulants should only be done under medical supervision. The potentiation of the effects of warfarin with continued high doses of paracetamol has been observed.

Medicines to increase urine production (loop diuretics such as furosemide): the effects of diuretics may be reduced.

Chloramphenicol, a medicine to treat infections: the simultaneous administration of paracetamol and chloramphenicol may significantly delay the elimination of chloramphenicol, increasing its plasma concentrations and causing a higher risk of toxicity.

Zidovudine (AZT), a medicine used in viral diseases: the concomitant administration of paracetamol and AZT may increase the incidence of neutropenia or worsen it (reduction of white blood cell count). Paracetamol should only be taken simultaneously with AZT if recommended by your doctor.

Flucloxacillin (antibiotic), due to a serious risk of alteration of blood and fluids (metabolic acidosis with high anion gap) that should be treated urgently (see section 2).

The concomitant use of substances that induce liver enzymes, such as barbiturates, carbamazepine, isoniazid, rifampicin, or ethanol, should be taken into account, as they may potentiate the toxic effect of paracetamol.

Inform your doctor if this medicine is taken with medicines that delay gastric emptying (e.g., propanteline) or that accelerate gastric emptying (e.g., metoclopramide and domperidone).

Use of Paracetamol with Food, Drinks, and Alcohol:

Do not drink alcohol during treatment with paracetamol.

Pregnancy and Breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist.

In case of need, Paracetamol can be used during pregnancy. You should use the lowest possible dose that reduces pain or fever and use it for the shortest possible time. Contact your doctor if the pain or fever does not decrease or if you need to take the medicine more frequently.

Paracetamol passes into breast milk, so breastfeeding women should consult their doctor or pharmacist before taking this medicine.

Driving and Using Machines

This medicine does not affect the ability to drive or use machines. However, during treatment with paracetamol, you may observe mild drowsiness and dizziness as side effects.

.

Paracetamol MABO-FARMA contains Sodium

This medicine contains less than 23 mg of sodium (1 mmol) per dose unit; it is essentially "sodium-free".

3. How to take Paracetamol MABO-FARMA

Follow the administration instructions of this medicine exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

The recommended dose is:

• Adults and adolescents over 15 years old (and weighing more than 55 kg): the recommended dose is 1 tablet or half (1 g - 500 mg of paracetamol) every 6 or 8 hours. If necessary, administration can be repeated after an interval of at least 4 hours.

Generally, it is not necessary to exceed 3 g of paracetamol per day, i.e., 3 tablets per day. However, for more intense pain, the maximum dose can be increased to 4 g per day (4 tablets).

There should always be a minimum interval of 4 hours between administrations.

Administration after meals may delay the onset of action.

Frequency of administration

Regular doses prevent variations in pain or temperature.

Liver diseases

Consult your doctor before taking this medicine.

Patient with moderate to severe kidney failure should not take this medicine.

Kidney diseases

Consult your doctor. Patients with moderate to severe impairment should not take this medicine.

Liver failure

You should take the amount prescribed by your doctor with a minimum interval of 8 hours.

Do not take more than 2 g of paracetamol (2 tablets) every 24 hours.

In chronic alcoholics, no more than 2 g/day of paracetamol should be administered.

Elderly patients

No dose adjustment is necessary.

Use in Children and Adolescents

This medicine should not be administered to children or adolescents under 15 years old with a weight of less than 55 kg.

For children with a weight over 33 kg between 13 and 15 years, 500 mg of paracetamol (half a tablet) can be administered 4 times a day with a large glass of water. The doses should be spaced at least 4 hours apart.

Maximum daily dose: 2 g/day.

Other presentations are available that do not require manipulation of the tablet.

Children (under 13 years). The use of this medicine is not recommended in these patients.

Method of administration:

Paracetamol MABO-FARMA should be taken orally.

The tablet can be divided into equal doses.

According to your preferences, the tablets can be ingested directly or broken in half, with the help of a glass of liquid, preferably water.

Consult your doctor or pharmacist if you have any doubts.

When lower doses of paracetamol are required, it is recommended to use other available presentations of paracetamol that adapt to the required dosage.

If you take more Paracetamol MABO-FARMA than you should:

Contact your doctor or pharmacist immediately, even if you feel well. The appearance of symptoms of severe liver damage may be delayed by 1 to 2 days. Adequate control of paracetamol overdose requires immediate treatment. Despite the absence of early symptoms, patients should be taken to the hospital for immediate treatment. The symptoms of overdose include nausea, vomiting, anorexia, pallor, general malaise, sweating, and abdominal pain and usually appear within the first 24 hours.

In case of overdose or accidental ingestion, go immediately to a medical center or call the Toxicology Information Service (telephone 91 562 04 20), indicating the medicine and the amount ingested.

If you forget to take Paracetamol MABO-FARMA:

If you forget to take a dose, take another as soon as you remember, unless it is almost time for your next dose. Remember to leave at least four hours between doses. Do not take a double dose to make up for forgotten doses.

If you stop taking Paracetamol MABO-FARMA

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible Side Effects

Like all medicines, this medicine can cause side effects, although not everyone gets them.

The following side effects have been reported in patients treated with paracetamol:

Rare:(may affect up to 1 in 1,000 people)

• Low blood pressure (hypotension).
• Increased liver enzymes.
• Malaise.

Very Rare:(may affect up to 1 in 10,000 people)

• Changes in the blood, including changes in blood cell counts (such as abnormally low levels of certain blood elements that can cause, for example, bleeding through the nose or gums) and bleeding.
• Allergic reactions (symptoms such as edema, shortness of breath, sweating, nausea, sudden drop in blood pressure).
• Decreased blood sugar.
• Jaundice (yellowing of the skin), liver failure.
• Skin reactions such as allergic dermatitis, urticaria, itching, skin rash.
• Changes in urination (difficult or painful urination, decreased amount of urine, and blood in the urine).

Frequency Not Known(cannot be estimated from available data): A serious disease called metabolic acidosis (an anomaly in the blood and fluids) in patients with serious illness using paracetamol (see section 2).

If you consider that any of the side effects you are experiencing is serious or if you notice any side effect not mentioned in this package leaflet, inform your doctor or pharmacist.

Reporting of Side Effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a side effect not listed in this package leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency's Pharmacovigilance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Paracetamol MABO-FARMA

Keep this medicine out of the sight and reach of children.

This medicine does not require special storage conditions.

Do not use this medicine after the expiration date stated on the packaging (after EXP.). The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the pharmacy's SIGRE point. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Package Contents and Additional Information

Composition of Paracetamol MABO-FARMA:

The active ingredient is paracetamol.

The other ingredients (excipients) are stearic acid, povidone, sodium carboxymethyl starch (type A) of potato, and pregelatinized maize starch.

Appearance of the Product and Package Contents:

Paracetamol MABO-FARMA 1 g is presented in the form of oral tablets.

The tablets are white or almost white, capsule-shaped, marked on one side with "10" and "00" on either side of the score line and on the other side with "PA" and "RA" on either side of the score line.

The boxes are of 20 or 40 tablets packaged in opaque PVC/Al blisters and transparent PVC/Al blisters. The tablet can be divided into equal doses.

Marketing Authorization Holder:

MABO-FARMA S.A.

Vía de los Poblados, 3, Edificio 6

28033 Madrid,

Spain.

Manufacturer:

Medis International a.s.

Prumyslova 961/16. Bolatice.

747 23, Czech Republic

or

Qualimetrix, S.A.

579 Mesogeion Avenue,

15343, Agia Paraskevi,

Athens, Greece

This package leaflet was approved in: February 2025

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/